Asia
System leverages artificial intelligence and shared decision-making to improve patient care at a low financial cost
Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan
IDMC recommends study can enrol children and infants aged from 21 days to 4 years
Vejthani Hospital in Bangkok announced the opening of a wound care center to offer comprehensive treatment for diabetic foot ulcers.
Contributing Further to Patients With Mycetoma, a Neglected Tropical Disease
BioSpace gathered together a roundup of global biopharma news from the past week. Bayer and Orion Corporation, Themis Bioscience, Axonics Modulation Technologies, and more are mentioned in this edition.
More news has come from China about the two babies born following He Jiankui’s experiment using CRISPR to make the children resistant to HIV while they were still embryos. Now, there is some evidence to suggest that the two infants could develop genetically-enhanced brains.
AbbVie announced that they have received approval for an additional indication of HUMIRA, a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa.
Lots of interesting biotech news from Asia, Europe and elsewhere was reported this week. From tapeworms to using a breathalyzer test in lung cancer diagnostics, the global biotech industry is exploding with ideas.
PRESS RELEASES